Pliant Therapeutics Appoints Craig Blanchette as Senior Vice President, Research (siRNA)

• Pliant Therapeutics appointed Craig Blanchette as senior vice president, research (siRNA).
• Blanchette joins from Switch Therapeutics, where he most recently served as chief scientific officer; he previously headed protein chemistry at Genentech.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610200830PRIMZONEFULLFEED9849140) on October 20, 2026, and is solely responsible for the information contained therein.